ReviewAsia-Pacific journal of clinical oncology2022

Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of advanced pancreatic cancer.

Masami Miki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.